Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Akebia Therapeutics (NQ: AKBA )

3.030 USD +0.050 (+1.68%)
Official Closing Price Updated: 7:52 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,452,500
Open 3.020
Bid (Size) 2.960 (2)
Ask (Size) 3.000 (1)
Prev. Close 2.980
Today's Range 2.890 - 3.030
52wk Range 2.090 - 13.71
Shares Outstanding 47,353,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive... 
From PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 19 newly-hired employees options to purchase an... 
From PR Newswire

Performance

YTD
+3.77%
+3.77%
1 Month
-15.83%
-15.83%
3 Month
-0.66%
-0.66%
6 Month
-14.65%
-14.65%
1 Year
-56.09%
-56.09%

More News

Read More
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
From PR Newswire
Akebia Therapeutics Announces Poster Presentations and Educational Symposium at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
From PR Newswire
Akebia Therapeutics Announces Approval for Additional Indication of Riona® (ferric citrate hydrate) for the Treatment of Iron Deficiency Anemia in Adult Patients in Japan
From PR Newswire
Akebia Therapeutics Celebrates World Kidney Day and National Kidney Month
From PR Newswire
4 Penny Stocks On Robinhood You Might’ve Missed This Week
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Akebia Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
From PR Newswire
Peek Under The Hood: XBI Has 65% Upside
Tags ETFs
From ETF Channel
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.